PharmagenDrx
  • Home
  • Our Services
    • Online Courses
    • Dose Daily
    • Career Counselling
  • Events
    • Conference
      • Upcoming
      • Past
      • Sponsored
    • Workshop
      • Upcoming
      • Past
      • Sponsored
    • Webinar
      • Upcoming
      • Past
      • Sponsored
  • Others
    • College Dictionary
      • Medical Colleges
      • Dental Colleges
      • Pharmacy colleges
      • Paramedical & Allied Colleges
    • Pharma EduPoint
    • Placement Stories
  • Submit Your Events
  • Contact
August 21, 2025 by admin

AIIMS Patna Declared as Centre of Excellence for Rare Diseases by MoHFW

AIIMS Patna Declared as Centre of Excellence for Rare Diseases by MoHFW
August 21, 2025 by admin

 

AIIMS Patna Declared as Centre of Excellence for Rare Diseases by MoHFW

PharmaGenDRx News Bureau- 20th August,2025

10:00 AM IST

All India Institute of Medical Sciences (AIIMS), Patna was declared as a Centre of Excellence (CoE) for Rare Diseases under the National Policy for Rare Diseases (NPRD), 2021 by the Ministry of Health and Family Welfare.

Hereby AIIMS Patna becomes another CoEs to provide advanced diagnosis, prevention and treatment for patients affected by rare diseases reaffirming the Government’s commitment towards uplifting the infrastructure of tertiary healthcare. This is a promising step towards safeguarding public healthcare.

With this move AIIMS Patna is endorsed with responsibilities to continue their work towards providing sufficient aid in the nation-wide fight against rare words.

By Sharon Bose and Arundhuti Chatterjee

 

LET’S KEEP IN TOUCH!

We’d love to keep you updated with our latest news and offers 😎

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

Previous articleSHRESTH Index Introduced by Union Health Ministry: Landmark Step Ensuring Drug Safety Nation-wideNext article CDSCO Warns Against Stolen Novo Nordisk Batches during Transit: Nationwide Alert on Insulin & Semaglutide Injections

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About The Blog

Nulla laoreet vestibulum turpis non finibus. Proin interdum a tortor sit amet mollis. Maecenas sollicitudin accumsan enim, ut aliquet risus.

Recent Posts

ICMR Notifies Amended HRD Scheme Guidelines Under Health Research ProgrammesJanuary 9, 2026
India Gets a New Hepatitis-E Vaccination Hevaxin by Dr. Reddy’sJanuary 8, 2026
Aurobindo Pharma’s Strategic Move: Acquires Khandelwal Labs Non-Oncology Prescription BusinessJanuary 6, 2026

Categories

  • Dose daily
  • Event Now
  • Past Webinar
  • Pharma Edupoint
  • Uncategorized
  • Upcoming Workshop

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Tags

Approval AUROBINDO PHARMA Cardiovascular CDSCO Compliance Cough syrup Daily news Diagnostic DIWALI Doctor Dose Daily Drug Drugs Drug safety Eli Lilly Fake FDA Fraud Global Collaboration GSK GST healthcare ICMR Illegal INDIA Industry Latest news MedTech MoHFW Nationwide NPPA Oncology Patient PCI pfizer Pharma Prescription Research RETAIL PRICE Roche UGC US USFDA WHO WORKSHOP

Why Us?

PharmaGenDRx is a platform bridging the gap between education and careers in pharma, lifescience and healthcare. It empowers students and professionals with industry-aligned training, certifications, and real-world skill development.

Contact

Newtown, Chakpachuria, West Bengal 700160
+917908584218
contact@pharmagendrx.com

QUICK LINKS

  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

 

© 2025 PHARMAGENDRX. All Rights are Reserved. Developed & Maintained by XMARTECH

About PharmaGenDRX

PharmaGenDRx is a platform bridging the gap between education and careers in pharma, lifescience and healthcare. It empowers students and professionals with industry-aligned training, certifications, and real-world skill development.

Recent Posts

ICMR Notifies Amended HRD Scheme Guidelines Under Health Research ProgrammesJanuary 9, 2026
India Gets a New Hepatitis-E Vaccination Hevaxin by Dr. Reddy’sJanuary 8, 2026
Aurobindo Pharma’s Strategic Move: Acquires Khandelwal Labs Non-Oncology Prescription BusinessJanuary 6, 2026

Categories

  • Dose daily
  • Event Now
  • Past Webinar
  • Pharma Edupoint
  • Uncategorized
  • Upcoming Workshop